Schonfeld Strategic Advisors LLC Vaxart, Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.6 - $1.41 $23,820 - $55,977	39,700 New	39,700 $28,000
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $50,736 - $109,242	24,276 Added 47.64%	75,234 $164,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $137,586 - $269,058	50,958 New	50,958 $179,000
Q3 2021 Nov 16, 2021	SELL	$6.67 - $9.8 $316,825 - $465,500	-47,500 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$5.06 - $10.78 $6,077 - $12,946	-1,201 Reduced 2.47%	47,500 $356,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $246,427 - $524,996	48,701 New	48,701 $365,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.